United States Files Complaint against Novartis Pharmaceuticals Corp. for Allegedly
Outcome
OIG enforcement action against United States Files Complaint against Novartis Pharmaceuticals Corp. for Allegedly for false claims, kickbacks.
Details
United States Files Complaint against Novartis Pharmaceuticals Corp. for Allegedly — OIG Enforcement (2026)
OIG took enforcement action against United States Files Complaint against Novartis Pharmaceuticals Corp. for Allegedly in 2026 involving false claims, kickbacks violations in the Independent Pharmacies sector.
Violation types: False Claims, Kickbacks
Entity type: Pharmacy
Penalty type: Settlement
Source: United States Files Complaint against Novartis Pharmaceuticals Corp. for Allegedly Paying Kickbacks to Doctors in Exchange for Prescribing Its Drugs
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery. Crucible's referral monitoring tracks patient source patterns and flags arrangements that correlate referral volume with financial relationships, enforcing anti-kickback compliance documentation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works